Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
about
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study.Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus.Identifying insulin treatment responders with a composite measure: beyond Hba1c < 7% in patients with type 2 diabetes.Characteristics of insulin-Naïve people with type 2 diabetes who successfully respond to insulin glargine U100 after 24 weeks of treatment: a meta-analysis of individual participant data from 3 randomized clinical trials.
P2860
Early Glycemic Response Predicts Achievement of Subsequent Treatment Targets in the Treatment of Type 2 Diabetes: A Post hoc Analysis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@ast
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@en
type
label
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@ast
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@en
prefLabel
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@ast
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@en
P2093
P2860
P1433
P1476
Early Glycemic Response Predic ...... Diabetes: A Post hoc Analysis
@en
P2093
Bradley Curtis
Dachuang Cao
Dara L Schuster
David M Kendall
Kristina S Boye
P2860
P2888
P304
P356
10.1007/S13300-015-0119-X
P577
2015-07-05T00:00:00Z